Antibiotic exposure does not influence MRP2 functional expression in Caco-2 cells

Journal of Drug Targeting

Volumn 13, Issue 1, 2005, Pages 1-6

  Prime Chapman, Hannah ^a,b   Moore, Vanessa ^b   Hirst, Barry H ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b ASTRAZENECA   (United Kingdom)

Author keywords

Antibiotics; Caco 2 cells; MRP; Multidrug resistance associated proteins; Oral bioavailability

Indexed keywords

ANTIBIOTIC AGENT; CALCEIN; GENTAMICIN; MULTIDRUG RESISTANCE PROTEIN 2; MULTIDRUG RESISTANCE PROTEIN 3; MULTIDRUG RESISTANCE PROTEIN 6; PENICILLIN G; STREPTOMYCIN;

APICAL MEMBRANE; ARTICLE; CELL CULTURE; CELL GROWTH; CELL STRAIN CACO 2; CONTROLLED STUDY; DRUG EXPOSURE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TRANSPORT;

ANTI-BACTERIAL AGENTS; CACO-2 CELLS; CALCIUM; CELL MEMBRANE STRUCTURES; CELL PROLIFERATION; DRUG COMBINATIONS; DRUG EVALUATION, PRECLINICAL; ELECTRIC IMPEDANCE; FLUORESCEINS; GENE EXPRESSION REGULATION; GENTAMICINS; HUMANS; MEMBRANE TRANSPORT PROTEINS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; PENICILLINS; STREPTOMYCIN; TIME FACTORS;

EID: 14644405046     PISSN: 1061186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/10611860400015944     Document Type: Article

References (20)

1. Bakos E, Evers R, Sinko E, Varadi A, Borst P, Sarkadi B. 2000. Interactions of the human multidrug resistance proteins MRP1 and MRP2 with organic anions, Mol Pharmacol 57, 760-768.
2. Chan LM, Lowes S, Hirst BH. 2004. The ABCs of drug transport in intestine and liver: efflux proteins limiting drug absorption and bioavailability, Eur J Pharm Sci 21:25-51.
3. Cui Y, Konig J, Buchholz JK, Spring H, Leier I, Keppler D. 1999. Drug resistance and ATP-dependent conjugate transport mediated by the apical multidrug resistance protein, MRP2, permanently expressed in human and canine cells, Mol Pharmacol 55:929-937.
4. Essodaigui M, Broxterman HJ, Gamier-Suillerot A. 1998. Kinetic analysis of calcein and calcein-acetoxymethylester efflux mediated by the multidrug resistance protein and P-glyco-protein, Biochemistry 37:2243-2250.
5. Evers R, Kool M, Van Deemter L, Janssen H, Calafat J, Oomen LC, Paulusma CC, Oude Elferink RP, Baas F, Schinkel AH, Borst P. 1998. Drug export activity of the human canalicular multi-specific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA, J Clin Investig 101:1310-1319.
6. Fromm MF, Kauffmann HM, Fritz P, Burk O, Kroemer HK, Warzok RW, Eichelbaum M, Siegmund W, Schrenk D. 2000. The effect of rifampin treatment on intestinal expression of human MRP transporters, Am J Pathol 157:1575-1580.
7. Gotoh Y, Suzuki H, Kinoshita S, Hirohashi T, Kato Y, Sugiyama Y. 2000. Involvement of an organic anion transporter (canalicular multispecific organic anion transporter/multidrug resistance-associated protein 2) in gastrointestinal secretion of glutathione conjugates in rats, J Pharmacol Exp Ther 292:433-439.
8. Greiner B, Eichelbaum M, Fritz P, Kreichgauer HP, von Richter O, Zundler J, Kroemer HK. 1999. The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin, J Clin Investig 104:147-153.
9. Hirohashi T, Suzuki H, Chu XY, Tamai I, Tsuji A, Sugiyama Y. 2000. Function and expression of multidrug resistance-associated protein family in human colon adenocarcinoma cells (Caco-2), J Pharmacol Exp Ther 292:265-270.
10. Hollo Z, Homolya L, Hegedus T, Sarkadi B. 1996. Transport properties of the multidrug resistance-associated protein (MRP) in human tumour cells, FEBS Lett 383:99-104.
11. Hunter J, Hirst BH. 1997. Intestinal secretion of drugs. The role of P-glycoprotein and related drug efflux systems in limiting oral drug absorption, Adv Drug Deliv Rev 25:129-157.
12. Marchal S, Merlin JL, Colosetti P, Finance C. 1999. Influence of the fluoroquinolone ofloxacin on the intrinsic expression of multidrug resistance phenotype in HCT-8 human colon carcinoma cells, Oncol Res 11:375-381.
13. Mottino AD, Hoffman T, Jennes L, Vore M. 2000. Expression and localization of multidrug resistant protein mrp2 in rat small intestine, J Pharmacol Exp Ther 293:717-723.
14. Pei QL, Kobayashi Y, Tanaka Y, Taguchi Y, Higuchi K, Kaito M, Ma N, Semba R, Kamisako T, Adachi Y. 2002. Increased expression of multidrug resistance-associated protein 1 (mrp1) in hepatocyte basolateral membrane and renal tubular epithelia after bile duct ligation in rats, Hepatol Res 22:58-64.
15. Prime-Chapman HM, Fearn RA, Cooper AE, Moore V, Hirst BH. 2004. Differential multidrug resistance-associated protein isoform 1 through 6 expression and function in human intestinal epithelial Caco-2 cells, J Pharmacol Exp Ther 311:476-484.
16. Scheffer GL, Kool M, Heijn M, de Haas M, Pijnenborg AC, Wijnholds J, Van Helvoort A, de Jong MC, Hooijberg JH, Mol CA, et al. 2000. Specific detection of multidrug resistance proteins MRP1, MRP2, MRP3, MRP5, and MDR3 P-glycoprotein with a panel of monoclonal antibodies, Cancer Res 60:5269-5277.
17. Schrenk D, Baus PR, Ermel N, Klein C, Vorderstemann B, Kauffmann HM. 2001. Up-regulation of transporters of the MRP family by drugs and toxins, Toxicol Lett 120:51-57.
18. Taipalensuu J, Tornblom H, Lindberg G, Einarsson C, Sjoqvist F, Melhus H, Garberg P, Sjostrom B, Lundgren B, Artursson P. 2001. Correlation of gene expression of ten drug efflux proteins of the ATP-binding cassette transporter family in normal human jejunum and in human intestinal epithelial Caco-2 cell monolayers, J Pharmacol Exp Ther 299:164-170.
19. Tanaka Y, Kobayashi Y, Gabazza EC, Higuchi K, Kamisako T, Kuroda M, Takeuchi K, Iwasa M, Kaito M, Adachi Y. 2002. Increased renal expression of bilirubin glucuronide transporters in a rat model of obstructive jaundice, Am J Physiol Gastrointest Liver Physiol 282:G656-G662.
20. Walgren RA, Karnaky KJ, Jr, Lindenmayer GE, Walle T. 2000. Efflux of dietary flavonoid quercetin 4′-beta-glucoside across human intestinal Caco-2 cell monolayers by apical multidrug resistance-associated protein-2, J Pharmacol Exp Ther 294:830-836.